Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award - Priority Announcement: Amyotrophic Lateral Sclerosis

University of Toronto

$39,000.00

Using proteomics to investigate the role of TDP-43 (TAR DNA-binding protein 43) in the pathogenesis of Amyotrophic Lateral Sclerosis

FY 2010-11

Summary
Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is an adult-onset neurodegenerative disease caused by degeneration of motor neurons in the brain and spinal cord. This devastating disease, with no cure and only one FDA-approved treatment to date, affects 1 in every 100,000 Canadians per year and causes muscle paralysis and eventual death, typically within 3-5 years. Mutations in the TAR DNA-binding protein 43 (TDP-43) have been linked to both sporadic and familial forms of ALS, and studies have shown that TDP-43 is present in the ubiquitinated inclusions found in affected motor neurons of ALS. Very little is known about the role of TDP-43 under physiological conditions and how it contributes to disease, therefore this project aims to elucidate the disease mechanism underlying motor neuron degeneration by identifying TDP-43 interacting proteins. A proteomic approach will be used, which involves the use of chemical crosslinking of TDP-43 to its interacting partners both in vitro and in vivo, immunoprecipitation of these complexes using TDP-43 antibody, and mass spectrometry to identify interacting proteins of TDP-43. This will be performed on human control and ALS brain and spinal cord tissues, as well as stable cell lines expressing wildtype and various pathological forms of TDP-43. Identifying TDP-43 interacting proteins will uncover specific biochemical pathways that underlie motor neuron degeneration, and will identify biomarkers for early diagnosis and potential candidates for therapeutics and genetic analyses.
Program
Doctoral Research Award - Priority Announcement: Amyotrophic Lateral Sclerosis
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
218763
Name
Chiang Yu-Shan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Amyotrophic Lateral Sclerosis Society of Canada
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Using proteomics to investigate the role of TDP-43 (TAR DNA-binding protein 43) in the pathogenesis of Amyotrophic Lateral Sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$39,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - Priority Announcement: Amyotrophic Lateral Sclerosis
Keyworddelim
Amyotrophic Lateral Sclerosis; Motor Neuron Disease; Neurodegenerative Disease; Protein-Protein Interaction; Stable Cell Line; Tar Dna-Binding Protein
Abstract
Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is an adult-onset neurodegenerative disease caused by degeneration of motor neurons in the brain and spinal cord. This devastating disease, with no cure and only one FDA-approved treatment to date, affects 1 in every 100,000 Canadians per year and causes muscle paralysis and eventual death, typically within 3-5 years. Mutations in the TAR DNA-binding protein 43 (TDP-43) have been linked to both sporadic and familial forms of ALS, and studies have shown that TDP-43 is present in the ubiquitinated inclusions found in affected motor neurons of ALS. Very little is known about the role of TDP-43 under physiological conditions and how it contributes to disease, therefore this project aims to elucidate the disease mechanism underlying motor neuron degeneration by identifying TDP-43 interacting proteins. A proteomic approach will be used, which involves the use of chemical crosslinking of TDP-43 to its interacting partners both in vitro and in vivo, immunoprecipitation of these complexes using TDP-43 antibody, and mass spectrometry to identify interacting proteins of TDP-43. This will be performed on human control and ALS brain and spinal cord tissues, as well as stable cell lines expressing wildtype and various pathological forms of TDP-43. Identifying TDP-43 interacting proteins will uncover specific biochemical pathways that underlie motor neuron degeneration, and will identify biomarkers for early diagnosis and potential candidates for therapeutics and genetic analyses.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chiang, Yu-Shan
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $39,000~ $0~